Cargando…
Targeting Epigenetics to Cure HIV-1: Lessons From (and for) Cancer Treatment
The Human Immunodeficiency Virus type 1 (HIV-1) integrates in the host genome as a provirus resulting in a long-lived reservoir of infected CD4 cells. As a provirus, HIV-1 has several aspects in common with an oncogene. Both the HIV-1 provirus and oncogenes only cause disease when expressed. A succe...
Autor principal: | Svensson, J. Peter |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8137950/ https://www.ncbi.nlm.nih.gov/pubmed/34026665 http://dx.doi.org/10.3389/fcimb.2021.668637 |
Ejemplares similares
-
Measuring the Success of HIV-1 Cure Strategies
por: Thomas, Jordan, et al.
Publicado: (2020) -
Editorial: Immunotherapies Towards HIV Cure
por: Salgado, Maria, et al.
Publicado: (2021) -
Promise and Progress of an HIV-1 Cure by Adeno-Associated Virus Vector Delivery of Anti-HIV-1 Biologics
por: Gardner, Matthew R.
Publicado: (2020) -
What Can Gamma Delta T Cells Contribute to an HIV Cure?
por: Juno, Jennifer A., et al.
Publicado: (2020) -
Block and Lock HIV Cure Strategies to Control the Latent Reservoir
por: Ahlenstiel, Chantelle L., et al.
Publicado: (2020)